Insulin pen company raises EUR 2.5m

The European Innovation Council has given Go-Pen a capital injection – proceeds that will be spent on developing and marketing a new, affordable, insulin pen.

Photo: Paul Chinn/AP/Ritzau Scanpix

Go-Pen has just received a EUR 2.5m injection from the European Innovation Council to continue developing the company’s new type of insulin pen, which promises affordability for all, writes Danish financial media Finans. An additional EUR 4m is at the ready if Go-Pen can find and match the same sum in external financing.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs